Erythrocytes as a controlled drug delivery system: clinical evidences.

Rossi, L; Serafini, S; Pierigé, F; Castro, M; Ambrosini, M I; Knafelz, D; Damonte, G; Annese, V; Latiano, A; Bossa, F; Magnani, M

Rossi, L; Serafini, S; Pierigé, F; Castro, M; Ambrosini, M I; Knafelz, D; Damonte, G; Annese, V; Latiano, A; Bossa, F; Magnani, M.

Affiliation

Rossi L; Institute of Biological Chemistry G. Fornaini, University of Urbino, Urbino, Italy. l.rossi@uniurb.it <l.rossi@uniurb.it>

J Control Release ; 116(2): e43-5, 2006 Nov 28.

Article in En | MEDLINE | ID: mdl-17718962

Subject(s)

Colitis, Ulcerative/drug therapy; Crohn Disease/drug therapy; Dexamethasone/analogs & derivatives; Drug Delivery Systems/methods; Erythrocytes; Adult; Child; Colitis, Ulcerative/blood; Crohn Disease/blood; Delayed-Action Preparations; Dexamethasone/administration & dosage; Dexamethasone/blood; Dexamethasone/chemistry; Dexamethasone/pharmacokinetics; Humans

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Dexamethasone / Colitis, Ulcerative / Crohn Disease / Drug Delivery Systems / Erythrocytes Limits: Adult / Child / Humans Language: En Journal: J Control Release Year: 2006 Document type: Article

Search on Google

XML

PubMed Links